Objectives The use of economic evidence to prioritise vaccines and delivery strategies to optimally use in immunisation systems is becoming a global priority, especially in low- and middle-income ...
Georg von Freymann loves his job. He is chief technology officer at the German start-up company Nanoscribe and, like his colleagues, frequently works long hours. “As a physicist, to see your ideas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback